[1] |
Zebrowski K,Chapel DB.Perivascular epithelioid cell tumor(PEComa)of the female genital tract[J].Int J Gynecol Cancer,2023,33(7):1160-1161.DOI:10.1136/ijgc-2022-004212.
|
[2] |
Wilhite AM,Dal Zotto V,Pettus P,et al.Perivascular epithelioid cell tumor (PEComa)of the uterus:challenges of pregnancy in determining prognosis and optimal treatment[J].Gynecol Oncol Rep,2022,40(1):100962.DOI:10.1016/j.gore.2022.100962.
|
[3] |
Cui Q,Li C,Huang T,et al.Systematic analysis of perivascular epithelioid cell neoplasms in the female reproductive tract:a comprehensive review [J].Future Oncol,2024,20(5):283-295.DOI:10.2217/fon-2023-0778.
|
[4] |
Katsakhyan L,Shahi M,Eugene HC,et al.Uterine leiomyosarcoma associated with perivascular epithelioid cell tumor:a phenomenon of differentiation/dedifferentiation and evidence suggesting cell-of-origin[J].Am J Surg Pathol,2024,48(6):761-772.DOI:10.1097/PAS.00000000 00002208.
|
[5] |
Bonetti F,Pea M,Martignoni G,et al.PEC and sugar[J].Am J Surg Pathol,1992,16(3):307-308.DOI:10.1097/00000478-199203000-00013.
|
[6] |
Zamboni G,Pea M,Martignoni G,et al.Clear cell"sugar"tumor of the pancreas.A novel member of the family of lesions characterized by the presence of perivascular epithelioid cells[J].Am J Surg Pathol,1996,20(6):722-730.DOI:10.1097/00000478-199606000-00010.
|
[7] |
Papoutsis D,Sahu B,Kelly J,et al.Perivascular epithelioid cell tumour and mesonephric adenocarcinoma of the uterine cervix:an unknown co-existence[J].Oxf Med Case Reports,2019,2019(1):omy115.DOI:10.1093/omcr/omy115.
|
[8] |
CaliòA,Brunelli M,Segala D,et al.Angiomyolipoma of the kidney:from simple hamartoma to complex tumour[J].Pathology,2021,53(1):129-140.DOI:10.1016/j.pathol.2020.08.008.
|
[9] |
Yan J,Zhou D,Wang Y,et al.A retrospective clinical analysis of 11 cases of PEComa from different sites[J].World J Surg Oncol,2024,22(1):116.DOI:10.1186/s12957-024-03349-x.
|
[10] |
Sharma A,Sharma R,Bala J,et al.Malignant perivascular epithelioid cell tumor of ovary:a rare case report[J].J Midlife Health,2025,16(1):107-109.DOI:10.4103/jmh.jmh_157_24.
|
[11] |
Bennett JA,Braga AC,Pinto A,et al.Uterine PEComas:a morphologic,immunohistochemical,and molecular analysis of 32 tumors[J].Am J Surg Pathol,2018,42(10):1370-1383.DOI:10.1097/PAS.0000000000001119.
|
[12] |
Garzon S,CaliòA,Ferrari FA,et al.Uterine perivascular epithelioid cell tumors (PEComa)and the accuracy of proposed classification systems in predicting the malignant versus non-malignant behavior[J].Gynecol Oncol,2024,188(1):35-43.DOI:10.1016/j.ygyno.2024.06.007.
|
[13] |
Folpe AL,Mentzel T,Lehr HA,et al.Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin:a clinicopathologic study of 26 cases and review of the literature[J].Am J Surg P athol,2005,29(12):1558-1575.DOI:10.1097/01.pas.0000173232.22117.37.
|
[14] |
Kudela E,Biringer K,Kasajova P,et al.Perivascular epithelioid cell tumors of the uterine cervix[J].Pathol Res Pract,2016,212(8):667-671.DOI:10.1016/j.prp.2016.03.010.
|
[15] |
Çelik H,Kefeli M,Çetinkaya M,et al.Perivascular epithelioid cell tumor (PEComa)of the uterine cervix in a patient with tuberous sclerosis complex:a literature review[J].Turk Patoloji Derg,2018,34(1):82-86.DOI:10.5146/tjpath.2014.01274.
|
[16] |
Fadare O.Uterine PEComa:appraisal of a controversial and increasingly reported mesenchymal neoplasm[J].Int Semin Surg Oncol,2008,5(1):7.DOI:10.1186/1477-7800-5-7.
|
[17] |
Hu D,Miao M,Zhou H,et al.A case report of malignant perivascular epithelioid cell tumors of the uterus and literature review[J].Int J Womens Health,2024,16(1):619-628.DOI:10.2147/IJWH.S453226.
|
[18] |
Fang CL,Lin YH,Chen WY.Microscopic endometrial perivascular epithelioid cell nodules:a case report with the earliest presentation of a uterine perivascular epithelioid cell tumor[J].Diagn Pathol,2012,7(1):117.DOI:10.1186/1746-1596-7-117.
|
[19] |
Fadare O.Perivascular epithelioid cell tumor (PEComa)of the uterus:an outcome-based clinicopathologic analysis of 41 reported cases[J].Adv Anat Pathol,2008,15(2):63-75.DOI:10.1097/PAP.0b013e31816613b0.
|
[20] |
Schoolmeester JK,Howitt BE,Hirsch MS,et al.Perivascular epithelioid cell neoplasm (PEComa)of the gynecologic tract:clinicopathologic and immunohistochemical characterization of 16 cases[J].Am J Surg Pathol,2014,38(2):176-188.DOI:10.1097/PAS.0000000000000133.
|
[21] |
Bennett JA,Pinto A.The "other"uterine mesenchymal neoplasms:recent developments and emerging entities[J].Adv Anat Pathol,2024,31(6):380-396.DOI:10.1097/PAP.0000000000000440.
|
[22] |
Kertowidjojo EC,Bennett JA.Update on uterine mesenchymal neoplasms[J].Surg Pathol Clin,2022,15(2):315-340.DOI:10.1016/j.path.2022.02.008.
|
[23] |
Bennett JA,Oliva E.Perivascular epithelioid cell tumors(PEComa)of the gynecologic tract[J].Genes Chromosomes Cancer,2021,60(3):168-179.DOI:10.1002/gcc.22908.
|
[24] |
Kundu R,Saha PK,Dey P.Sclerosing perivascular epithelioid cell tumor of the uterus:a rare entity posing diagnostic challenge[J].J Midlife Health,2022,13(4):328-330.DOI:10.4103/jmh.jmh_120_22.
|
[25] |
Selenica P,Conlon N,Gonzalez C,et al.Genomic profiling aids classification of diagnostically challenging uterine mesenchymal tumors with myomelanocytic differentiation[J].Am J Surg Pathol,2021,45(1):77-92.DOI:10.1097/PAS.0000000000001572.
|
[26] |
Liu CH,Chao WT,Lin SC,et al.Malignant perivascular epithelioid cell tumor in the female genital tract:preferred reporting items for systematic reviews and Meta-analyses[J].Medicine(Baltimore),2019,98(2):e14072.DOI:10.1097/MD.0000000000014072.
|
[27] |
Schoolmeester JK,Dao LN,Sukov WR,et al.TFE3 translocation-associated perivascular epithelioid cell neoplasm(PEComa)of the gynecologic tract:morphology,immunophenotype,differential diagnosis[J].Am J Surg Pathol,2015,39 (3):394-404.DOI:10.1097/PAS.0000000000000349.
|
[28] |
Cao B,Huang Y.Malignant perivascular epithelioid cell tumor (PEComa)of the uterus[J].BMC Womens Health,2022,22(1):523.DOI:10.1186/s12905-022-02119-9.
|
[29] |
Giannella L,Delli Carpini G,Montik N,et al.Ultrasound features of a uterine perivascular epithelioid cell tumor(PEComa):case report and literature review[J].Diagnostics(Basel),2020,10(8):553.DOI:10.3390/diagnostics 10080553.
|
[30] |
Gadducci A,Zannoni GF.Perivascular epithelioid cell tumors(PEComa)of the female genital tract:a challenging question for gynaecologic oncologist and pathologist[J].Gynecol Oncol Rep,2020,33(1):100603.DOI:10.1016/j.gore.2020.100603.
|
[31] |
Croce S,Devouassoux-Shisheboran M,Pautier P,et al.Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential.Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group[J].Gynecol Oncol,2022,167(2):373-389.DOI:10.1016/j.ygyno.2022.07.031.
|
[32] |
Natella V,Merolla F,Giampaolino P,et al.A huge malignant perivascular epithelioid cell tumor (PEComa)of the uterine cervix and vagina[J].Pathol Res Pract,2014,210(3):186-188.DOI:10.1016/j.prp.2013.10.003.
|
[33] |
Gadducci A,Ugolini C,Cosio S,et al.Primary perivascular epithelioid cell tumor (PEComa)of the ovary:a case report and review of the literature[J].Anticancer Res,2021,41(9):4483-4488.DOI:10.21873/anticanres.15258.
|
[34] |
Jiang Y,Liu X,Zhang S,et al.Risk stratification and outcomes in 210 gynecologic perivascular epithelioid cell tumors (PEComas)cases[J].Arch Gynecol Obstet,2023,307(3):681-687.DOI:10.1007/s00404-022-06470-y.
|
[35] |
Sanfilippo R,Jones RL,Blay JY,et al.Role of chemotherapy,VEGFR inhibitors,and m TOR inhibitors in advanced perivascular epithelioid cell tumors(PEComas)[J].Clin Cancer Res,2019,25(17):5295-5300.DOI:10.1158/1078-0432.CCR-19-0288.
|
[36] |
Sanfilippo R,Fabbroni C,FucàG,et al.Addition of antiestrogen treatment in patients with malignant PEComa progressing to m TOR inhibitors[J].Clin Cancer Res,2020,26(20):5534-5538.DOI:10.1158/1078-0432.CCR-20-1191.
|
[37] |
Ferrari FA,Garzon S,CaliòA,et al.2022-RA-1535-ESGO uterine PEComa and prognostic value of the proposed classification systems:a retrospective study,systematic review,and Meta analysis[J].Int J Gynecol Cancer,2022,32(Sup2):2.DOI:10.1136/ijgc-2022-ESGO.461.
|